UK Companies House feature
SOLTA MEDICAL UK LIMITED
Cash
£213K
+423.6% vs 2023
Net assets
—
Equity attributable
Employees
12
+71.4% vs 2023
Profit before tax
£78K
+905.6% vs 2023
Profile
- Company number
- 13551206
- Status
- Active
- Incorporation
- 2021-08-06
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 86210
- Hubs
- UK Healthcare
Net assets
3-year trend · vs UK Healthcare median
Accounts
3-year trend · latest 2024-12-31
| Metric | Trend | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|
| Turnover | — | — | — | |
| Operating profit | — | — | — | |
| Profit before tax | — | £7,788 | £78,320 | |
| Net profit | — | — | £60,621 | |
| Cash | £100,001 | £40,761 | £213,440 | |
| Total assets less current liabilities | — | — | — | |
| Net assets | £100,001 | — | — | |
| Equity | £100,001 | £106,309 | £166,930 | |
| Average employees | — | 7 | 12 | |
| Wages | — | — | — |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102 §1A
- Reporting scope
- Standalone (parent only)
- Abridged
- Yes — abridged accounts (limited disclosure)
- Auditor
- Bourner Bullock
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the entity's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Significant events
- “No adjusting post balance sheet events have occurred to date and the Directors have a reasonable expectation that there will be no significant impact to the company's financial results.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
5 active · 2 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CSC CLS (UK) LIMITED | Corporate Secretary | 2026-01-28 | — | — |
| DONNELLAN, Ruth Lillis | Director | 2024-03-30 | Oct 1986 | Irish |
| JASINSKI, David Martin | Director | 2025-04-25 | May 1979 | Polish |
| KENNAN, Michael Anthony | Director | 2021-08-06 | Apr 1968 | Irish |
| WOODFIELD, William Norman | Director | 2025-04-25 | Jan 1976 | American |
Show 2 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CORPORATION SERVICE COMPANY (UK) LIMITED | Corporate Secretary | 2023-11-20 | 2026-01-28 |
| KIM, Jiny Ok Jin | Director | 2024-03-30 | 2025-04-08 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Bausch Health Companies Inc. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-08-06 | Active |
Filing timeline
Last 20 of 22 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-02-16 | CH01 | officers | change person director company with change date |
| 2026-01-30 | AP04 | officers | appoint corporate secretary company with name date |
| 2026-01-30 | AD01 | address | change registered office address company with date old address new address |
| 2026-01-30 | TM02 | officers | termination secretary company with name termination date |
| 2026-01-22 | AA | accounts | accounts with accounts type full |
| 2025-11-17 | CH01 | officers | change person director company with change date |
| 2025-08-12 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-05-28 | AP01 | officers | appoint person director company with name date |
| 2025-05-28 | AP01 | officers | appoint person director company with name date |
| 2025-04-25 | TM01 | officers | termination director company with name termination date |
| 2024-09-26 | AA | accounts | accounts with accounts type total exemption full |
| 2024-08-12 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-04-12 | AP01 | officers | appoint person director company with name date |
| 2024-04-11 | AP01 | officers | appoint person director company with name date |
| 2024-01-24 | AD01 | address | change registered office address company with date old address new address |
| 2024-01-24 | AP04 | officers | appoint corporate secretary company with name date |
| 2023-08-08 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-06-21 | AA | accounts | accounts with accounts type dormant |
| 2022-08-25 | CS01 | confirmation-statement | confirmation statement with updates |
| 2022-01-05 | SH01 | capital | capital allotment shares |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory